RHUMBLINE ADVISERS - KRONOS BIO INC ownership

KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 71 filers reported holding KRONOS BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of KRONOS BIO INC
ValueSharesWeighting
Q3 2023$2,714
-74.8%
2,088
-66.6%
0.00%
Q2 2023$10,760
+11724.2%
6,256
-89.9%
0.00%
Q1 2023$91
-8.1%
62,159
+1.4%
0.00%
Q4 2022$99
-100.0%
61,310
+0.1%
0.00%
Q3 2022$205,0000.0%61,229
+8.8%
0.00%
Q2 2022$205,000
-41.8%
56,255
+15.4%
0.00%
Q1 2022$352,000
-49.6%
48,728
-5.2%
0.00%
-100.0%
Q4 2021$698,000
-36.0%
51,385
-1.2%
0.00%0.0%
Q3 2021$1,090,000
-9.4%
51,989
+3.5%
0.00%
-50.0%
Q2 2021$1,203,000
+170.3%
50,246
+230.8%
0.00%
+100.0%
Q1 2021$445,000
+13.2%
15,190
+15.5%
0.00%0.0%
Q4 2020$393,00013,1560.00%
Other shareholders
KRONOS BIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,765,314$4,037,3585.52%
Omega Fund Management, LLC 3,818,283$5,574,6933.64%
Nextech Invest Ltd. 1,451,537$2,119,2440.88%
Wildcat Capital Management, LLC 1,297,959$1,895,0200.70%
Privium Fund Management (UK) Ltd 292,182$455,8040.36%
CM Management, LLC 180,000$2630.31%
Artal Group S.A. 1,542,954$2,2530.13%
Alphabet Inc. 1,438,232$2,099,8190.12%
Perceptive Advisors 1,752,745$2,558,1310.08%
GSA CAPITAL PARTNERS LLP 406,362$5930.06%
View complete list of KRONOS BIO INC shareholders